Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|80|5|1149-1159

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.5, 2015-11, pp. : 1149-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public

By Chan Sze Ling Wen Low Joshua Jun Lim Yee Wei Finkelstein Eric Farooqui Muhammad Assad Chia Kee Seng Wee Hwee Lin

Personalized Medicine, Vol. 10, Iss. 2, 2013-03 ,pp. : 127-137

Future Medicine

Access to resources Recommend Favorite

Clinical pharmacy consultation for pharmacogenetic testing

By Shin Jaekyu Kayser Steven R

Personalized Medicine, Vol. 6, Iss. 2, 2009-03 ,pp. : 183-192

Future Medicine

Access to resources Recommend Favorite

Attitudes of Health Care Professionals Toward Pharmacogenetic Testing

By Zgheib Nathalie K.

Molecular Diagnosis & Therapy, Vol. 15, Iss. 2, 2011-04 ,pp. : 115-122

Adis International

Access to resources Recommend Favorite

Cost‐effectiveness of screening for HLA‐A*31:01 prior to initiation of carbamazepine in epilepsy

EPILEPSIA, Vol. 56, Iss. 4, 2015-04 ,pp. : 556-563

John Wiley & Sons Inc

Access to resources Recommend Favorite

Obtaining genetic testing in pediatric epilepsy

EPILEPSIA, Vol. 56, Iss. 10, 2015-10 ,pp. : 1505-1514

John Wiley & Sons Inc

Access to resources Recommend Favorite